ID: ALA3678077

Max Phase: Preclinical

Molecular Formula: C16H24F2N2O2

Molecular Weight: 314.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCOc1ccc(F)c(CCNCC(=O)N(C)C)c1F

Standard InChI:  InChI=1S/C16H24F2N2O2/c1-4-5-10-22-14-7-6-13(17)12(16(14)18)8-9-19-11-15(21)20(2)3/h6-7,19H,4-5,8-11H2,1-3H3

Standard InChI Key:  NUAHCZNEPOUXAO-UHFFFAOYSA-N

Associated Targets(non-human)

Monoamine oxidase B 2209 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 314.38Molecular Weight (Monoisotopic): 314.1806AlogP: 2.36#Rotatable Bonds: 9
Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.23CX LogP: 2.39CX LogD: 1.50
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.71Np Likeness Score: -1.36

References

1.  (2015)  Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators, 

Source

Source(1):